Orthobiologics Market Major players are Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson

According to a new report published by Allied Market Research, titled,"Orthobiologics Market by Product, Application, Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the market was valued at $4,870 million in 2017, and is projected to reach $6,870 million by 2025, growing at a CAGR of 4.3% from 2018 to 2025.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/845?utm_source=openpr&utm_medium=Niranjan

Orthobiologics are substances that orthopedic surgeons utilize to help injuries heal more quickly. These products are made from substances that are naturally found in the human body. These are used to improve the healing of broken bones and injured muscles, tendons, and ligaments.

The key factors that drive the growth of the global orthobiologics market are an increased demand for advanced treatment and rise in prevalence of osteoarthritis, degenerative arthritis, spinal injuries, and soft tissue injuries majorly drive the growth of the market. Further, the rise in obesity rate, growth in awareness among the patients, and an increase in geriatric population support the market growth. However, the high cost of procedures and stringent regulatory approval process restrict the growth of this market. Advancements in implant technologies and growth in demand for biological solutions create opportunities for market growth.

The global orthobiologics market is segmented based on product, application, type, end user, and region. Based on product, the market is classified into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others. Viscosupplementation products are the largest and fastest growing segment. This is due to its application for the treatment of knee pain associated with osteoarthritis. Increase in geriatric population, a rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity, drive the adoption of viscosupplement products.

For Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/845?utm_source=openpr&utm_medium=Niranjan

Based on the type, the market is categorized into the knee, ankle, hip, wrist & shoulder, spine, and others. The knee segment held the largest share in the market in 2017; this is due to the rise in the number of aged patients undergoing knee replacement procedures. A spine is a fastest growing segment due to the rise in the number of sports-related injuries to the spine.

Based on application, the market is categorized into an application such as osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, maxillofacial, and dental applications. Osteoarthritis & degenerative arthritis is the largest segment due to the increase in the prevalence of these conditions. Spinal fusion was the fastest growing segment in 2017 owing to the benefits offered by orthobiologics in the treatment.

Based on the end user, the market is categorized into hospitals & ambulatory centers, research & academic institute, and dental clinics. The hospitals & ambulatory centers segment held the largest share in the market in 2017 and is the fastest growing segment as these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings of the Orthobiologics Market:
• North America occupied more than half of the share of the global orthobiologics market in 2017.
• The spinal fusion segment is anticipated to grow with a CAGR of 4.9% during the forecast period.
• The knee segment accounted for more than one-third share of the market in 2017.
• Asia-pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
• North America was the leading revenue contributor to the global market in 2017, garnering nearly more than half of the total market share, owing to high purchasing power.
• Rise in the elderly population, favorable reimbursement rates, increase in the prevalence of orthopedic disorders even among the younger population, and surge in the number of road & sports, However.
• Asia-Pacific is expected to grow at the highest CAGR of 5.7% from 2018 to 2025, owing to an increase in disposable income; surge in obesity, sports-related accidents; and rise in awareness related to different orthobiologics.

The report provides an extensive competitive analysis and profiles of the key market players such as Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc.

3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Porters five forces analysis

3.3. Market dynamics

3.3.1. Drivers
3.3.1.1. The rise in the incidence of orthopedic diseases & injury
3.3.1.2. Growth in the aging population
3.3.1.3. Increase in sports injuries

3.3.2. Restraints
3.3.2.1. The high cost of the orthobiologics product
3.3.2.2. Stringent approval process

3.3.3. Opportunity
3.3.3.1. Improvement in healthcare infrastructure

3.4. Top player positioning, 2017

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.